FARNUM RHONDA (SVP, Comm & Medical Affairs) sold 5.4% of their position (13.31K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $218.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/17/2026ACC: 0001898490-26-000010
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-13.31K
Net shares
Net seller
$218.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
13.31K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−3.33K
Price / share
$16.39
Trade value
$54.56K
% of position
1.4%
6/15/2026
245.77K→242.44K
Ordinary Shares
Direct
Shares
−3.33K
Price / share
$16.38
Trade value
$54.53K
% of position
1.4%
6/15/2026
242.44K→239.11K
Ordinary Shares
Direct
Shares
−6.66K
Price / share
$16.39
Trade value
$109.08K
% of position
2.8%
6/15/2026
239.11K→232.46K
Total
Net shares
−13.31K
Net value
-$218.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/15/2026 | S · Sale | −3.33K | $16.39 | $54.56K | 1.4% | 245.77K | 242.44K |
| Ordinary Shares Direct | 6/15/2026 | S · Sale | −3.33K | $16.38 | $54.53K | 1.4% | 242.44K | 239.11K |
| Ordinary Shares Direct | 6/15/2026 | S · Sale | −6.66K | $16.39 | $109.08K | 2.8% | 239.11K | 232.46K |
| Total | −13.31K | -$218.17K | ||||||
Derivative Transactions0
No derivative transactions reported